Skip to content
Every compound links to batch-tested stock at Nordapep, with a Certificate of Analysis per batch.
peptide.wiki

PT-141

PT-141 (bremelanotide) is a cyclic heptapeptide derived from melanotan II. It is an FDA-approved medicine for one indication and a standard reference for MC4R research.

Approved in the US onlyMelanocortin receptorsCyclic melanocortin-receptor agonist5/55/5

At a glance

5/55/5
Class
Melanocortin receptor agonist
Receptor targets
MC4R (also MC1R)
Length
7 amino acids (cyclic)
Molecular mass
≈ 1.03 kDa
Origin
Synthetic, derived from melanotan II
Research area
Melanocortin receptors
Also known as
Bremelanotide

What PT-141 is

Bremelanotide is a metabolite-derived analogue of melanotan II that acts mainly on melanocortin receptors in the central nervous system, especially MC4R.

It is approved by the FDA for a narrow indication, which gives it a stronger evidence base than most peptides in this category.

What the research literature studies

  • MC4R signalling and receptor-selectivity assays
  • Central melanocortin pathways in animal models
  • Cyclic peptide structure and stability

Evidence rating: 5/5

Approved drug, phase 3 trials. Approved in the US for one indication on the strength of phase 3 trials. See our methodology for how levels are assigned.

  • Approval covers one indication in one region; it says nothing about other uses.

Regulatory status

Bremelanotide is FDA-approved as a prescription medicine for one indication. It has no MHRA or EMA authorisation at the time of writing. Research-grade material is not that medicine and must not be used in people or animals.

Reviewed November 2026.

PT-141 at Nordapep: sizes and price per mg

Every size, its price and the cost per milligram, so you can choose the best-value vial for your protocol.

Not currently listed at Nordapep.

Compare PT-141

PT-141 FAQ

PT-141 or Melanotan II?

PT-141 is derived from melanotan II but is more selective for central melanocortin receptors. See the comparison page.

Where can I buy PT-141 for research?

Nordapep does not currently list PT-141. You can ask Nordapep about availability, or compare related compounds that are in stock.

Is PT-141 approved?

Bremelanotide is FDA-approved as a prescription medicine for one indication. It has no MHRA or EMA authorisation at the time of writing. Research-grade material is not that medicine and must not be used in people or animals.

Key terms for PT-141

Further reading

Cite this page

peptide.wiki. (2026). PT-141: research peptide profile. peptide.wiki. https://www.peptide.wiki/peptides/pt-141
Free to cite and link. Last reviewed November 2026.
For laboratory research only. Nothing on peptide.wiki is medical advice. The compounds described are not for human or veterinary use, and research-grade material is not a medicine.

Related compounds